Skip to main content
Premium Trial:

Request an Annual Quote

Lentigen Licenses UPenn s Lentiviral Vector Tech for Reagent, Dx Development

NEW YORK, May 22 (GenomeWeb News) - Lentigen has received an exclusive worldwide license from the University of Pennsylvania to use its lentiviral vector technology, the company said today.

 

According to the company, the technology can be used to deliver genes or RNAi molecules into cells. The license gives Lentigen the right to use the technology to develop research reagents and therapeutics.

 

Financial terms of the arrangement were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.